161 related articles for article (PubMed ID: 27025841)
1. Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.
Pyo JH; Hong SN; Min BH; Lee JH; Chang DK; Rhee PL; Kim JJ; Choi SK; Jung SH; Son HJ; Kim YH
J Gastroenterol; 2016 Dec; 51(12):1112-1121. PubMed ID: 27025841
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with rectal neuroendocrine tumors: a cross-sectional study.
Jung YS; Yun KE; Chang Y; Ryu S; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Park DI
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1406-13. PubMed ID: 24813818
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors.
Ko SH; Baeg MK; Ko SY; Jung HS
Surg Endosc; 2017 Oct; 31(10):3864-3871. PubMed ID: 28078467
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.
Hassan MM; Phan A; Li D; Dagohoy CG; Leary C; Yao JC
Int J Cancer; 2008 Aug; 123(4):867-73. PubMed ID: 18491401
[TBL] [Abstract][Full Text] [Related]
5. Is metabolic syndrome a risk factor for colorectal adenoma?
Kim JH; Lim YJ; Kim YH; Sung IK; Shim SG; Oh SO; Park SS; Yang S; Son HJ; Rhee PL; Kim JJ; Rhee JC; Choi YH
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1543-6. PubMed ID: 17684126
[TBL] [Abstract][Full Text] [Related]
6. Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis.
Haugvik SP; Basim Ibrahim I; Hedenström P; Valente R; Hayes AJ; Siuka D; Gladhaug IP; Capurso G
Scand J Gastroenterol; 2017 Aug; 52(8):797-802. PubMed ID: 28394712
[TBL] [Abstract][Full Text] [Related]
7. Relation of family history of cancer and environmental factors to the risk of colorectal cancer: a case-control study.
Kotake K; Koyama Y; Nasu J; Fukutomi T; Yamaguchi N
Jpn J Clin Oncol; 1995 Oct; 25(5):195-202. PubMed ID: 7474407
[TBL] [Abstract][Full Text] [Related]
8. Clinico-epidemiologic study of the metabolic syndrome and lifestyle factors associated with the risk of colon adenoma and adenocarcinoma.
Kaneko R; Sato Y; An Y; Nakagawa M; Kusayanagi S; Kamisago S; Umeda T; Ogawa M; Munakata K; Mizuno K
Asian Pac J Cancer Prev; 2010; 11(4):975-83. PubMed ID: 21133610
[TBL] [Abstract][Full Text] [Related]
9. The relation of smoking, alcohol use and obesity to risk of sigmoid colon and rectal adenomas.
Honjo S; Kono S; Shinchi K; Wakabayashi K; Todoroki I; Sakurai Y; Imanishi K; Nishikawa H; Ogawa S; Katsurada M
Jpn J Cancer Res; 1995 Nov; 86(11):1019-26. PubMed ID: 8567391
[TBL] [Abstract][Full Text] [Related]
10. Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study.
Rinzivillo M; Capurso G; Campana D; Fazio N; Panzuto F; Spada F; Cicchese N; Partelli S; Tomassetti P; Falconi M; Delle Fave G
Neuroendocrinology; 2016; 103(5):531-7. PubMed ID: 26356731
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of and risk factors for colorectal neoplasms in young adults in a screening population.
Lee SE; Jo HB; Kwack WG; Jeong YJ; Yoon YJ; Kang HW
World J Gastroenterol; 2016 Mar; 22(10):2981-92. PubMed ID: 26973394
[TBL] [Abstract][Full Text] [Related]
12. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women.
Cho GJ; Shin JH; Yi KW; Park HT; Kim T; Hur JY; Kim SH
Menopause; 2011 Oct; 18(10):1120-4. PubMed ID: 21694651
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of atypical endoscopic features in rectal neuroendocrine tumors.
Hyun JH; Lee SD; Youk EG; Lee JB; Lee EJ; Chang HJ; Sohn DK
World J Gastroenterol; 2015 Dec; 21(47):13302-8. PubMed ID: 26715813
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
[TBL] [Abstract][Full Text] [Related]
15. Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control study.
Hassan MM; Phan A; Li D; Dagohoy CG; Leary C; Yao JC
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):959-65. PubMed ID: 18398037
[TBL] [Abstract][Full Text] [Related]
16. [Rectal neuroendocrine tumors: surgical therapy].
Radulova-Mauersberger O; Stelzner S; Witzigmannn H
Chirurg; 2016 Apr; 87(4):292-7. PubMed ID: 26888707
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase polymorphism, alcohol intake, and risks of colon and rectal cancers in Korea.
Kim DH; Ahn YO; Lee BH; Tsuji E; Kiyohara C; Kono S
Cancer Lett; 2004 Dec; 216(2):199-205. PubMed ID: 15533596
[TBL] [Abstract][Full Text] [Related]
18. Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme.
Basuroy R; O'Donnell CM; Srirajaskanthan R; Ramage JK
Colorectal Dis; 2018 Apr; 20(4):O85-O91. PubMed ID: 29368418
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.
Nishikawa Y; Chino A; Ide D; Saito S; Igarashi M; Takamatsu M; Fujisaki J; Igarashi Y
Int J Colorectal Dis; 2019 Nov; 34(11):1887-1894. PubMed ID: 31630212
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical characteristics of gastroenteropancreatic neuroendocrine tumor in Korea: a single-center experience.
Lim CH; Lee IS; Jun BY; Kim JS; Cho YK; Park JM; Roh SY; Lee MA; Kim SW; Choi MG
Korean J Intern Med; 2017 May; 32(3):452-458. PubMed ID: 28490723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
